Understanding Advanced Therapies in Inflammatory Arthritis – A New Tool

We are very excited to announce that the Canadian Spondylitis Association has added a great tool for patients to their…

3 years ago

New Autoinjector For Risankizumab (Skyrizi)

Many of the advanced therapies for autoimmune diseases are protein-based medications we refer to as biologics. To avoid stomach digestion,…

3 years ago

Pharmacy Appreciation Month

March is the month we celebrate the pharmacy profession, and the role pharmacists play in patient care.  As pharmacists at…

3 years ago

Understanding Biosimilars and Non-Medical Switch: The Details

At Charlton Health we specialize in providing biologic medications for many autoimmune conditions.  Some of these medications have been on…

3 years ago

Traveling with A Biologic Medication

Many of our patients have indicated they are planning a vacation over the winter months to a sunny destination. It…

3 years ago

Publicly Funded Shingles Vaccine Program Expanded

Publicly funded shingles vaccination has been available for many years for adults aged 65-70. Initially, the vaccine provided was Zostavax,…

3 years ago

What’s in store for 2023…

Happy New Year to our Charlton Family! We enter 2023 with much excitement as treatments for autoimmune diseases continue to…

3 years ago

Our Top Blogs of 2022

As we near the end of 2022, we thought we would share some of our most popular blog posts of…

3 years ago

Preventing Falls

According to Health Canada’s guidance on fall prevention, falls are the leading cause of injury among older Canadians.  In fact,…

3 years ago

Skyrizi (risankizumab): Newest Treatment for Crohn’s Disease

On October 20, 2022, Health Canada granted approval for SKYRIZI® (risankizumab) as the latest addition for the treatment of moderate-severe Crohn’s disease.…

3 years ago